Samuel Halliday

Sam is a registered pharmacist in Australia with over fifteen years' experience in the health system with previous roles as a community pharmacy manager, accredited Consultant Pharmacist and examiner for the Pharmacy Board of Australia.

He was awarded a Bachelor of Pharmacy and the JC Burgin Memorial Prize for outstanding commitment and dedication to academic studies from the University of Tasmania in 2006.

Sam was awarded a Master of Public Health from the University of Tasmania in August 2018. In October 2018 he was awarded a Winston Churchill Memorial Trust Fellowship for travel overseas in 2019 to investigate international approaches to the regulation of medical cannabis. In February 2019 he graduated from the Tasmanian Leaders Program, an intensive year-long action-learning program focused on building leadership capacity and connectivity across Tasmania.

Sam has worked in medicines regulation since 2013 and is currently the Deputy Chief Pharmacist fo the Tasmanian Government's Department of Health, regulating the application of the Poisons Act 1971 as it relates to the manufacture, distribution and use of drugs of dependence, medicines, poisons and therapeutic goods in Tasmania. This work includes the stewardship of Australia's first Real Time Prescription Monitoring system for high-risk pharmaceutical medicines. He is Tasmania's nominated member of the Australian Government Therapeutic Goods Administration's (TGA) Advisory Committee on Medicines Scheduling and Advisory Committee on Chemicals Scheduling.

Sam also sits on the TGA's Medicinal Cannabis Access Working Group and the Australian Government Office of Drug Control's Medicinal Cannabis Cultivation and Production Working Group. In his spare time he enjoys spending time with his family and friends, and playing golf.